Fernando

Teams from across BC join the BOOST QI Network Annual Congress virtually

Uncategorized / By

The Best-practices in Oral Opioid AgoniSt Therapy (BOOST) Annual Congress was held last month amidst the dual public health emergencies of the COVID-19 pandemic and the opioid overdose crisis. Presenters at the congress shared how their teams are adapting their practices for the pandemic, how healthcare teams can better integrate the voices of families of those with opioid use disorder (OUD), and also shared ideas on how to support and improve retention for clients on opioid agonist therapy (OAT).

Teams from across BC join the BOOST QI Network Annual Congress virtually Read More »

New BC-CfE research improves our knowledge and validation of the HIV reservoir

Uncategorized / By

A recently published paper, in the scientific journal Virus Evolution, by a BC-CfE doctoral student provides a way for phylogenetic and other molecular studies of HIV reservoirs to be validated. This vital research will help in the understanding of the dynamics of the HIV-1 reservoir, thus bringing us closer to a durable HIV-1 cure

New BC-CfE research improves our knowledge and validation of the HIV reservoir Read More »

Dr. Julio Montaner profiled in BIV’s LifeSciences magazine

Uncategorized / By

Business in Vancouver’sLifesciencesmagazine recently profiled BC-CfE Executive Director & Physician-in-Chief Dr. Julio Montaner. In the profile, the history of Dr. Montaner’s career is traced from his arrival in Vancouver from Argentina in the 1980s, to the creation of Highly Active Antiretroviral Therapy (HAART), up to the global spread of the cost-saving strategy of Treatment as Prevention¨ (TasP¨) .

Dr. Julio Montaner profiled in BIV’s LifeSciences magazine Read More »

BOOST and Coast Mental Health Collaboration Improves Lives of Those Living With OUD

Uncategorized / By

More than 1,300 people have died from illicit drug poisoning in BC so far this year. Some months saw a death toll greater than double the same month the previous year, and June alone had 183 people die of an overdose. This was the highest monthly overdose related death toll in BC’s history.

BOOST and Coast Mental Health Collaboration Improves Lives of Those Living With OUD Read More »

BC-CfE’s Dr. Jeffrey Joy’s vital COVID-19 research published in Science

Uncategorized / By

The BC-CfE’s Dr. Jeffrey Joy has joined an international team of researchers in the fight against COVID-19. Dr. Joy, a Senior Research Scientist specializing in evolutionary genetics, molecular epidemiology and bioinformatics at the BC-CfE, is also an Assistant Professor of Medicine at the University of British Columbia.

BC-CfE’s Dr. Jeffrey Joy’s vital COVID-19 research published in Science Read More »

Dr. Val Montessori, St. Paul’s Hospital new Head of Division of Infectious Diseases

Uncategorized / By

Earlier this year Providence Health Care announced Dr. Val Montessori as the new Head of its Division of Infectious Diseases in the Department of Medicine at St. Paul’s Hospital (SPH). We spoke with Dr. Montessori to find out what inspires and informs her work as she takes on this important new role.

Dr. Val Montessori, St. Paul’s Hospital new Head of Division of Infectious Diseases Read More »

BC-CfE’s Nance Cunningham, Experimental Medicine PhD student, chosen as a UBC Public Scholar

Uncategorized / By

The BC-CfE’s Nance Cunningham, an Experimental Medicine PhD student working in the EMBARC team (Epidemiological, Mathematical and Biostatistical analysis and Research Collaboration in HIV/AIDS) has been chosen as a UBC Public Scholar.The Public Scholars Initiative (PSI)supports creative, action-oriented research designed to address complex challenges and have meaningful public impact as part of a PhD thesis. The award will support Cunningham’s research partnerships with people affected by hepatitis C, and patient advocacy activists.

BC-CfE’s Nance Cunningham, Experimental Medicine PhD student, chosen as a UBC Public Scholar Read More »

BC-CfE researcher first to identify link between severe intimate partner violence and all-cause mortality among women living with HIV

Uncategorized / By

Globally, one in three women will experience some form of intimate partner violence in their lives. Some North American studies indicate this may be much more likely for women living with HIV. Despite improvements in HIV disease outcomes among women living with HIV in BC, multiple interacting inequities continue to disproportionately impact the health, wellbeing, and survival of women living with HIV.

BC-CfE researcher first to identify link between severe intimate partner violence and all-cause mortality among women living with HIV Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search